Clinical Trial

A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A study of XTMAB-16 in patients with pulmonary sarcoidosis
Trial Details
NCT Number NCT07680166
Lead Sponsor Xentria, Inc.
Conditions Pulmonary Sarcoidosis
Enrollment 182 participants
Start Date 2026-10-30
Primary Completion 2029-10-31 (estimated)
Study Completion 2029-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-02